DocGo

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DocGo reports stellar 2022 performance and outlines growth strategies

DocGo's strong financial performance in 2022, coupled with robust guidance for 2023 and strategic operational initiatives, positions the company for continued growth and profitability.
While challenges like managing PHE impacts and transitioning to leased hour contracts exist, DocGo's proactive approach and operational strengths provide a solid foundation for addressing these hurdles.
With a focus on optimizing operations, pursuing growth opportunities, and leveraging its financial resources effectively, DocGo is poised to capitalize on market opportunities and deliver value to stakeholders.

DocGo reports Q1 revenue growth amidst margin challenges and future opportunities

DocGo's Q1 2023 performance showcased revenue growth and margin challenges, with a focus on improving margins through normalization initiatives.
Strengths include strong revenue guidance, significant contract opportunities, and partnerships driving backlog growth and revenue diversification.
Challenges stem from replacing high-margin COVID revenue, startup costs impacting margins, and negative cash flow in Q1 2023.
Opportunities lie in future revenue growth from new contracts, RPM services, public-private partnerships, and potential contract wins from upcoming RFPs.

DocGo (DCGO) reports stellar Q2 results, raises full-year guidance

DocGo's Q2 2023 showcased exceptional financial performance, with revenue and EBITDA growth exceeding expectations, underpinned by strong operational metrics and strategic decisions.
While facing challenges in backlog conversion and margin improvements, the company's focus on scalability, employee satisfaction, and market expansion positions it well for future growth.
Opportunities in new geographies, Remote Patient Monitoring integration, and transportation segment enhancements provide avenues for sustained revenue growth and operational excellence.

DocGo reports record Q3 revenue, eyes growth in commercial sector

DocGo's Q3 performance reflects strong revenue growth and improved EBITDA margins, driven by the success of Mobile Health and Transportation Services. While facing challenges with working capital and payment delays, the company is focused on catching up by year-end.
The company's strengths in contract performance, revenue guidance increase, and backlog diversification position it well for future growth. DocGo's strategic focus on commercial business expansion and customer experience enhancement aligns with its growth objectives.

DocGo reports record Q4 earnings, eyes growth in healthcare

DocGo delivered exceptional financial results in Q4 2023, showcasing robust revenue growth and profitability, driven by operational excellence and strategic investments.
While facing margin and cost challenges, the company's focus on growth, value-based care agreements, and revenue diversification positions it well for future success and market expansion.
With a strong cash position, revised revenue guidance, and proactive pursuit of new partnerships, DocGo is poised to capitalize on growth opportunities and navigate challenges effectively.
The company's commitment to transforming healthcare delivery and gratitude towards its staff underscore a resilient corporate culture and a dedication to driving positive impact in the industry.

DocGo reports robust Q1 earnings, eyes growth through unique care model

DocGo's Q1 2024 performance was strong, marked by revenue growth, improved margins, and profitability.
While facing challenges like revenue fluctuations and working capital pressures, the company is well-positioned for growth.
Opportunities lie in becoming a primary care provider, monetization strategies, and market differentiation through quality care.
Overall, DocGo's financial stability, growth plans, and unique service offerings position them for future success in the healthcare sector.

DocGo excels in Q2 2024, sets sights on clinical innovation

DocGo's Q2 2024 performance reflects financial strength and strategic advancements in clinical expertise and service expansion.
While facing challenges in meeting ambitious care gap closure targets, the company is well-positioned for growth.
Leveraging opportunities in mobile healthcare services and clinical program development can drive future success for DocGo.

DocGo reports robust Q3 earnings, eyes growth in migrant-related work

DocGo's Q3 2024 earnings call showcased strong financial performance, operational efficiency, and positive outlook for future revenue and cash flow.
While challenges such as revenue balancing and margin expectations were noted, opportunities for growth through migrant-related work and care programs were highlighted.
Overall, DocGo's performance and strategic direction position the company well for continued success and expansion in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

I believe DCGO remains undervalued and has strong growth prospects. Recent results show significant revenue growth and an increase in FY23 revenue guidance. Despite concerns about contract rejection, DCGO has a strong relationship with the New York City government and is well-positioned to address the issue.

DocGo: Growth Significantly Exceeded My Expectations

LOS ANGELES, CA / ACCESSWIRE / November 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Nov. 27, 2023 /PRNewswire/ -- Attention DocGo Inc. ("DocGo") (NASDAQ: DCGO) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between November 8, 2022 and September 17, 2023. If you suffered a loss on your investment in DocGo, contact us about potential recovery by using the link below.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind DocGo Investors of a Lead Plaintiff Deadline of December 26, 2023

LOS ANGELES, CA / ACCESSWIRE / November 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Nov. 26, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

LOS ANGELES, CA / ACCESSWIRE / November 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

Upcoming Lead Plaintiff Deadline is December 26, 2023 NEW YORK , Nov. 21, 2023 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of those who acquired DocGo Inc. ("DocGo" or the "Company") (NASDAQ: DCGO) securities during the period from November 8, 2022 through September 17, 2023, inclusive (the "Class Period"). A ll investors who purchased shares and incurred losses are advised to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

DocGo Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against DocGo Inc.

LOS ANGELES, CA / ACCESSWIRE / November 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

INVESTOR DEADLINE NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Nov. 18, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DocGo Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO.

DOCGO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options

LOS ANGELES, CA / ACCESSWIRE / November 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 16, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 26, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). If you suffered a loss on your DocGo investments or would like to inquire about potentially pursuing claim.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DocGo Inc. (DCGO)

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming December 26, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). Investors suffering losses on their DocGo investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal right.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DocGo Inc. (DCGO)

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DocGo To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in DocGo between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO.

DOCGO INVESTOR DEADLINE APPROACHING

NEW YORK , Nov. 11, 2023 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). DocGo investors have until December 26, 2023 to file a lead plaintiff motion. If you suffered a loss on your DocGo investme.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of DocGo Inc. (DCGO) Investors

SAN DIEGO--(BUSINESS WIRE)---- $DCGO #DocGoInc--DocGo Inc. (DCGO) Misled Investors Regarding the Efficacy of its Mobile Health and Medical Transportation Services.

DCGO Stock News: DocGo Inc. Shareholders Should Contact Robbins LLP Regarding Their Rights in the Class Action Filed Against DocGo Inc. (DCGO)

NEW YORK--(BUSINESS WIRE)---- $DCGO #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities during the period from November 8, 2022 through September 17, 2023, inclusive (the “Class Period”). Investors have until December 26, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit. On July 30,.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of DocGo Inc. (DCGO) Investors and Encourages Investors to Contact the Firm Before December 26, 2023

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning DocGo business and prospects, resulting in its stock trading at inflated prices.

DCGO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DocGo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of technology-enabled mobile health services (Nasdaq: DCGO), today announced that the company will be participating in the following investor conferences during the month of November. Needham & Company 4th Annual Tech Week November 15, 2023 – Virtual 1x1 investor meetings, contact your Needham representative for additional information. Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum November 16, 2023 – 1x1 in.

DocGo Announces Attendance at November 2023 Investor Conferences

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). DocGo investors have until December 26, 2023 to file a lead plaintiff motion. Investors suffering losses on their DocGo investments are encouraged to contact the Law Offices of Howard G. Smith to discu.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of DocGo Inc. (DCGO) Investors

DocGo Inc. (NASDAQ:DCGO ) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants Mike Cole - Director of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Treasurer and Chief Financial Officer Conference Call Participants Sarah James - Cantor Fitzgerald Richard Close - Cannacord Genuity David Larsen - BTIG Mike Latimore - Northland Capital Markets David Grossman - Stifel Ryan MacDonald - Needham & Co Pito Chickering - Deutsche Bank Operator Greetings, and welcome to the DocGo Third Quarter 2023 Earnings Conference Call. At this time all participants are in listen-only mode.

DocGo Inc. (DCGO) Q3 2023 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2023. Q3 2023 Financial Highlights Total revenue for the third quarter of 2023 was $186.6 million, up 49% from $125.5 million in the second quarter of 2023 and up 79% from $104.3 million in the third quarter of 2022. The revenue increase was driven by gains in nearly a.

DocGo Announces Record Third Quarter 2023 Results

NEW YORK , Nov. 4, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

News for DocGo Stock (DCGO)